Immunexpress Sponsored Webinar: The Role of a Host Response Test, SeptiCyte RAPID, to Improve Sepsis Bundle Compliance and Address Diagnostic Uncertainty

Immunexpress Sponsored Webinar: The Role of a Host Response Test, SeptiCyte RAPID, to Improve Sepsis Bundle Compliance and Address Diagnostic Uncertainty

4.75 (4 votes)

Webinar Description: 

In this sponsored webinar, Roy Davis, MD, PhD, MHA, Chief Medical Officer of Immunexpress, will introduce SeptiCyte RAPID, a one-hour, FDA-cleared test to differentiate sepsis from non-infectious systemic inflammation,. Dr. Davis will also share clinical validation data and describe its impact in sepsis bundle compliance. Russell Miller, MD, MPH, FCCM, will then explain the clinical value of SeptiCyte RAPID, especially when there is diagnostic uncertainty in patients suspected of sepsis, and why this led to its adoption at his hospital.

No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.

Webinar Sponsor: 

Sepsis Alliance gratefully acknowledges the support provided by Immunexpress for this sponsored webinar.

image


Roy F. Davis MD, PhD, MHA

Chief Medical Officer

Immunexpress

Roy F. Davis MD, PhD, MHA, has 30 years’ experience in clinical medicine (neonatal and pediatric critical care) and hospital administration. He was Clinical Assistant Professor in the Department of Pediatrics at the University of Washington and has served as a consultant in health care standards and quality of care delivered. He implemented MEWS and sepsis surveillance algorithms while serving as Chief Medical Officer at Providence Alaska, winning a national Microsoft Healthcare Innovation Award. At Immunexpress, he has been involved in the development and clinical validation of SeptiCyte RAPID and its role of in the diagnosis of sepsis.

Russell R. Miller, MD, MPH, FCCM

Medical Director of Critical Care

FirstHealth of the Carolinas

Russell R. Miller, MD, MPH, FCCM, is an Intensivist and Medical Director of Critical Care at FirstHealth of the Carolinas in Pinehurst, North Carolina. Previously, he was Chair of the Critical Care Development Team for Intermountain Healthcare and Director of the Respiratory ICU at Intermountain Medical Center. He completed his undergraduate training at Duke University, medical and residency training in the southeast United States, and then a Pulmonary and Critical Care Medicine fellowship at Vanderbilt University. His academic interests have included sepsis, pneumonia and associated lung injury, sedation and delirium in the ICU, and ICU mobility.

Components visible upon registration.